Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...

The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation ...

An Ontario woman with epilepsy is living seizure-free... after a device was surgically implanted in her skull. The ...

Repeated sessions of electrical stimulation to brain networks associated with memory improved verbal learning in some ...

New Health Canada Approval Allows Spark Biomedical to Offer Drug-Free Opioid Withdrawal Relief Across Canada.Dallas, TX, ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

The global pain management devices market is set to experience robust growth, with sales projected to rise from USD 3,019.8 ...

The global extracorporeal membrane oxygenation machine market is on a growth trajectory, with revenue anticipated to reach ...

UCSD has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for treating mTBI and PTSD.

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain, today ...

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company” or "Nexalin”) the leader in Deep Intracranial Frequency ...

Sleep Apnea Implants MarketThe global sleep apnea implants market is projected to grow at a CAGR of 3.8% from 2024 to 2035, ...